Oruka Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $46.5M | $49.1M |
| FY2021 | — | $51.0M | $53.4M |
| FY2022 | — | $41.7M | $42.4M |
| FY2023 | — | $37.0M | $37.4M |
| FY2024 | — | $1.0K | $61.6M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $46.5M | $49.1M |
| FY2021 | — | $51.0M | $53.4M |
| FY2022 | — | $41.7M | $42.4M |
| FY2023 | — | $37.0M | $37.4M |
| FY2024 | — | $1.0K | $61.6M |